Universe Pharmaceuticals (UPC) Receivables - Net (2020 - 2025)
Universe Pharmaceuticals' Receivables - Net history spans 6 years, with the latest figure at $13.0 billion for Q3 2025.
- On a quarterly basis, Receivables - Net rose 0.79% to $13.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $13.0 billion, a 0.79% increase, with the full-year FY2025 number at $13.0 billion, up 0.79% from a year prior.
- Receivables - Net hit $13.0 billion in Q3 2025 for Universe Pharmaceuticals, up from $12.9 billion in the prior quarter.
- Over the last five years, Receivables - Net for UPC hit a ceiling of $13.0 billion in Q3 2025 and a floor of $11.0 million in Q3 2023.
- Historically, Receivables - Net has averaged $3.3 billion across 5 years, with a median of $16.5 million in 2021.
- Biggest five-year swings in Receivables - Net: dropped 27.46% in 2023 and later soared 117066.85% in 2024.
- Tracing UPC's Receivables - Net over 5 years: stood at $15.6 million in 2021, then dropped by 2.5% to $15.2 million in 2022, then dropped by 27.46% to $11.0 million in 2023, then soared by 117066.85% to $12.9 billion in 2024, then increased by 0.79% to $13.0 billion in 2025.
- Business Quant data shows Receivables - Net for UPC at $13.0 billion in Q3 2025, $12.9 billion in Q3 2024, and $14.4 million in Q1 2024.